Back to Search Start Over

Daily image guidance with cone-beam computed tomography for head-and-neck cancer intensity-modulated radiotherapy: a prospective study

Authors :
James M. Galvin
Greg Bednarz
Robert B. Den
Mitchell Machtay
Ying Xiao
Greg Kubicek
William M. Keane
Anthony Doemer
Source :
International journal of radiation oncology, biology, physics. 76(5)
Publication Year :
2008

Abstract

Purpose To report on a prospective clinical trial of the use of daily kilovoltage cone-beam computed tomography (CBCT) to evaluate the interfraction and residual error motion of patients undergoing intensity-modulated radiotherapy for head-and-neck cancer. Methods and Materials Patients were treated with intensity-modulated radiotherapy with an Elekta linear accelerator using a mounted CBCT scanner. CBCT was performed before every treatment, and translational (but not rotational) corrections were performed. At least once per week, a CBCT scan was obtained after intensity-modulated radiotherapy. Variations were measured in the medial–lateral, superoinferior, and anteroposterior dimensions, as well as in the rotation around these axes. Results A total of 28 consecutive patients (1,013 CBCT scans) were studied. The average interfraction shift was 1.4 ± 1.4, 1.7 ± 1.9, and 1.8 ± 2.1 mm in the medial–lateral, superoinferior, and anteroposterior dimensions, respectively. The corresponding average residual error shifts were 0.7 ± 0.8, 0.9 ± 0.9, and 0.9 ± 0.9 mm. These data indicate that in the absence of daily CBCT image-guided radiotherapy, a clinical target volume to planning target volume margin of 3.9, 4.1, and 4.9 mm is needed in the medial–lateral, superoinferior, and anteroposterior dimensions, respectively. With daily CBCT, corresponding margins of 1.6, 2.5, and 1.9 mm should be acceptable. Subgroup analyses showed that larynx cancers and/or intratreatment weight loss indicate a need for slightly larger clinical target volume to planning target volume margins. Conclusion The results of our study have shown that image-guided radiotherapy using CBCT for head-and-neck cancer is effective. These data suggest it allows a reduction in the clinical target volume to planning target volume margins by about 50%, which could facilitate future studies of dose escalation and/or improved toxicity reduction. Caution is particularly warranted for cases in which the targets are mobile ( e.g., the tongue).

Details

ISSN :
1879355X
Volume :
76
Issue :
5
Database :
OpenAIRE
Journal :
International journal of radiation oncology, biology, physics
Accession number :
edsair.doi.dedup.....1a2d427168a923cc7c3de2e99329ee35